Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Hairless mice lack fur due to a genetic mutation affecting skin response, not hormone issues.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.